Canaccord Genuity analyst Matt Bottomley maintained a Buy rating on Curaleaf Holdings (OTC:CURLF) on Tuesday, setting a price target of C$16, which is approximately 28.57% above the present share price of $9.43.
Bottomley expects Curaleaf Holdings to post earnings per share (EPS) of -$0.03 for the third quarter of 2020.
The current consensus among 9 TipRanks analysts is for a Strong Buy rating of shares in Curaleaf Holdings, with an average price target of $12.38.
The analysts price targets range from a high of $18 to a low of $6.06.
In its latest earnings report, released on 03/31/2020, the company reported a quarterly revenue of $96.5 million and a net profit of $4.99 million. The company's market cap is $4.98 billion.
According to TipRanks.com, Canaccord Genuity analyst Matt Bottomley is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 9.0% and a 51.83% success rate.
Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how, and back office administration, intellectual property licensing,real estate leasing services, and lending facilities to medical and adult-use cannabis licensee. The company was founded on November 13, 2014 and is headquartered in Vancouver, Canada.